Written by Wassim Aldairy, Head of Pharmacovigilance and Clinical Safety @ Cerevel Therapeutics
When implementing a pharmacovigilance system at Cerevel it was very important to us to document and track all actions related to drug safety. As a clinical stage company, those requirements included tracking signals from non-clinical sources, any safety related clinical datasets such as vital signs, lab values, and safety scales, and of course traditional clinical sources such adverse event data.
Read More